Status:
UNKNOWN
Reduced Dissemination of Tumor Cells With Primary Ligation of the Vein in Patients With Lung Cancer
Lead Sponsor:
West China Hospital
Conditions:
Lung Cancer
Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the impact of the sequence of vessel interruption in lung cancer patients on tumor cell spread and patient survival by using peripheral blood circulating tumor c...
Detailed Description
Circulating tumor cells (CTCs) in the peripheral blood can be a biomarker to predict tumor recurrence and survival. Handling the tumor during a surgery may promote the release of CTCs into the bloodst...
Eligibility Criteria
Inclusion
- Patients with stage I-IV lung cancer eligible for surgery
- Patients undergoing the completely thoracoscopic lobectomy
- The nodule size was more than 2.5 cm
- Patients consenting for intraoperative blood sampling
Exclusion
- Patients who underwent primary wedge resection and open lobectomy
- Patients who received neoadjuvant therapy before surgery
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03436329
Start Date
December 1 2016
End Date
December 31 2020
Last Update
October 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital, Sichuan University
Chengdu, Sichuan, China, 610041